Recent insights into angiogenesis, apoptosis, invasion, and metastasis in colorectal carcinoma

被引：40

作者：

Boedefeld, WM ^{[1
]}

Bland, KI ^{[1
]}

Heslin, MJ ^{[1
]}

机构：

[1] Univ Alabama, Dept Surg, Birmingham, AL 35243 USA

来源：

ANNALS OF SURGICAL ONCOLOGY | 2003年 / 10卷 / 08期

关键词：

angiogenesis; apoptosis; invasion; colorectal carcinoma;

D O I：

10.1245/ASO.2003.02.021

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The numerous studies profiling mechanisms in colorectal carcinoma have implicated multiple pathways in the malignant progression of a colorectal epithelial cell. Such pathways as aberrations in the cell cycle, deviation from apoptosis, neovascularization of tumors, and invasion and metastasis of malignant epithelial cells have been shown to occur in the progression of a normal epithelial cell to an adenoma and carcinoma. Today, we continue to search for communications or connections between these pathways as we try to get a more global picture of the events responsible for the adenoma-carcinoma sequence. This review focuses on the latest developments of three well-characterized pathways implicated in colorectal carcinoma: angiogenesis, apoptosis, and invasion and metastasis. We will attempt to highlight clinical correlates, when available, with some of the more interesting molecules.

引用

收藏

页码：839 / 851

页数：13

相关论文

共 124 条

[11] Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization [J].

Bleuel, K ;

Popp, S ;

Fusenig, NE ;

Stanbridge, EJ ;

Boukamp, P .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) :2065-2070

[12] A NOVEL PROTEIN THAT INTERACTS WITH THE DEATH DOMAIN OF FAS/APO1 CONTAINS A SEQUENCE MOTIF RELATED TO THE DEATH DOMAIN [J].

BOLDIN, MP ;

VARFOLOMEEV, EE ;

PANCER, Z ;

METT, IL ;

CAMONIS, JH ;

WALLACH, D .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (14) :7795-7798

[13] Proapoptotic Bcl-2 relative bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity [J].

Bouillet, P ;

Metcalf, D ;

Huang, DCS ;

Tarlinton, DM ;

Kay, TWH ;

Köntgen, F ;

Adams, JM ;

Strasser, A .

SCIENCE, 1999, 286 (5445) :1735-1738

[14] Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial [J].

Bramhall, SR ;

Hallissey, MT ;

Whiting, J ;

Scholefield, J ;

Tierney, G ;

Stuart, RC ;

Hawkins, RE ;

McCulloch, P ;

Maughan, T ;

Brown, PD ;

Baillet, M .

BRITISH JOURNAL OF CANCER, 2002, 86 (12) :1864-1870

[15] A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer [J].

Bramhall, SR ;

Schulz, J ;

Nemunaitis, J ;

Brown, PD ;

Baillet, M ;

Buckels, JAC .

BRITISH JOURNAL OF CANCER, 2002, 87 (02) :161-167

[16]

Brizel DM, 1996, CANCER RES, V56, P5347

[17] THE C-TERMINAL REGION OF MEMBRANE TYPE MATRIX METALLOPROTEINASE IS A FUNCTIONAL TRANSMEMBRANE DOMAIN REQUIRED FOR PRO-GELATINASE-C ACTIVATION [J].

CAO, J ;

SATO, H ;

TAKINO, T ;

SEIKI, M .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (02) :801-805

[18] Conversion of Bcl-2 to a Bax-like death effector by caspases [J].

Cheng, EHY ;

Kirsch, DG ;

Clem, RJ ;

Ravi, R ;

Kastan, MB ;

Bedi, A ;

Ueno, K ;

Hardwick, JM .

SCIENCE, 1997, 278 (5345) :1966-1968

[19] Modulation of cell death by Bcl-xL through caspase interaction [J].

Clem, RJ ;

Cheng, EHY ;

Karp, CL ;

Kirsch, DG ;

Ueno, K ;

Takahashi, A ;

Kastan, MB ;

Griffin, DE ;

Earnshaw, WC ;

Veliuona, MA ;

Hardwick, JM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :554-559

[20] Interleukin 6 induces the expression of vascular endothelial growth factor [J].

Cohen, T ;

Nahari, D ;

Cerem, LW ;

Neufeld, G ;

Levi, BZ .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :736-741

← 1 2 3 4 5 6 7 8 9 10 →